Cardiac Resynchronisation Therapy (CRTD)

Implantation of a defibrillator device to coordinate heart contractions

Cardiac Resynchronisation Therapy (CRTD) is recommended when non-surgical treatments have failed, when the condition significantly affects quality of life, or when imaging confirms the need for intervention. Your Cardiac Electrophysiology surgeon will assess your suitability after a detailed consultation.

Cardiac Resynchronisation Therapy (CRTD) is typically performed under Local anesthesia. Your anaesthetist will review your health history, medications, and allergies before the procedure to ensure safety.

Most patients recover within 2-4 weeks, though this varies by individual health, age, and compliance with physiotherapy. Light activities can usually resume within a few weeks; full recovery takes longer.

As with any surgical procedure, risks include bleeding, infection, anaesthesia reactions, and rare complications such as injury to adjacent structures. Your surgeon will discuss your personal risk profile during the consent process.

Cardiac Resynchronisation Therapy (CRTD) has a documented success rate of 88% when performed by qualified surgeons at accredited hospitals. Outcomes depend on the patient's overall health, disease severity, and adherence to post-operative care.